RedBird Farms and Smashburger® Announce Nationwide Partnership to Launch the Chicken Smash®
The Chicken Smash® is a ground chicken patty marinated in-house with a signature garlic olive oil seasoning, delivering bold flavor and a juicy, tender texture. True to Smashburger®'s commitment to customization, the Chicken Smash® can be swapped seamlessly onto any burger build on the menu, giving guests a delicious alternative to the classic beef patty while maintaining the same level of quality and flavor that Smashburger® is known for.
'Better Chicken for a Better Burger Experience'
'At RedBird Farms, we're committed to providing the highest quality chicken, humanely raised with No Antibiotics Ever (NAE),' said Mareo Torito, owner of RedBird Farms. 'We're thrilled to partner with Smashburger® to bring this commitment to life in the Chicken Smash®. This collaboration allows guests across the country to enjoy a ground chicken option that's both flavorful and versatile.'
A Smashburger® Innovation
Known for its signature smash technique, Smashburger® delivers bold, flavorful smash burgers and burger-relevant sides. As a market-unique creation not seen at other restaurants, the Chicken Smash® represents the brand's attention to detail with each ingredient, recipe, and menu offering, ensuring the evolving preferences of customers are met at a high standard. Guests can enjoy the Chicken Smash® as part of a classic build or customize it with premium add-ons such as bacon, avocado, grilled onions, or house-made truffle mayo.
'We're all about leveling up the Smashburger® dining experience, and the Chicken Smash® is a perfect example of doing just that,' said Jim Sullivan, President at Smashburger®. 'Partnering with RedBird Farms ensures we're delivering a ground chicken option that matches the quality and taste our guests expect.'
Whether enjoyed as a signature menu item or as a customized creation, the Chicken Smash® offers a satisfying, protein-packed option for chicken lovers and burger enthusiasts alike.
For more information about the Chicken Smash® or to find a Smashburger® location near you, visit www.Smashburger.com.
About RedBird Farms
RedBird Farms has been a trusted name in premium fresh chicken for over 80 years, offering all-natural, high-quality poultry products. Based in Colorado but available throughout the U.S., the family-owned company is dedicated to providing chicken that is raised with No Antibiotics Ever, fed an all-vegetarian diet, humanely raised and cage-free, allergen and gluten-free, and contains no additives, preservatives, or added hormones. Learn more about RedBird Farms at www.redbirdfarms.com.
About Smashburger®
Smashburger® is a leading fast-casual better burger restaurant known for its Certified Angus Beef® burgers that are smashed on the grill to sear in the juices and seal in the flavor. In addition to burgers, Smashburger® offers veggie burgers, signature side items such as SmashFries® and SmashTots®, and hand-spun shakes. Founded in 2007 in Denver, Colorado, Smashburger® is recognized as a 2023 Stevie American Business Award winner for Achievement in Product Innovation, named one of the 2023 Top Workplaces by The Denver Post and ranked as one of Fast Casual's top 50 brands in its 2024 Top 100 Movers & Shakers Award. The brand has 235 corporate and franchise restaurants operating in 31 states and seven countries. To learn more, visit www.Smashburger.com.
Gigi Nally
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
22 minutes ago
- CNBC
The complete guide to applying for student loans in 2025
You've finished applying to college, got accepted and made your decision. Now it's time to apply again, this time for financial aid. Whether you're looking to cover the full cost or just fill in the gaps, student loans can help make college more affordable by spreading out the payments over time. Here's how to apply for a student loan, step by step. The first step is to fill out the Free Application for Federal Student Aid (FAFSA). This is your gateway to federal student loans, grants and work-study. You can complete it at and it's completely free. To fill out the FAFSA, you will need some important documents: File as early as possible to maximize your aid. Some aid is first-come, first-served. After your school gets your FAFSA, they'll send you a financial aid award letter. This will break down any grants or scholarships you're eligible for, work-study offers (if applicable) and federal student loan options, such as Direct Subsidized or Unsubsidized Loans. You'll be able to accept all or part of the loan offer through your school's financial aid portal. Before receiving the funds, you must also: If your federal aid doesn't fully cover your costs, you can apply for a private student loan through a bank, credit union or online lender. However, keep in mind: Be sure to compare multiple lenders for the best terms. Earnest offers student loans with four repayment terms and a nine-month grace period. If you have a FICO® Score of 650 or better, you can also apply without a cosigner. Ascent also offers a generous grace period of up to 36 months, along with 1% cash back on your principal loan at graduation. And if you're enrolled in an outcomes-based loan program, you can get a rate reduction of up to 1.0% for setting up autopay. Undergraduate and graduate students, parents, half-time students, international and DACA students Undergraduate, graduate loans, parent loans, MBA, medical school, law school, international and DACA student loans $1,000 up to the cost of attendance for new loans, $5,000 to $550,000 for refinance loans 5, 7, 10, 12, 15 years Nine-month grace period available No Yes - click here for details Terms apply.2.98% to 15.61% APR with autopay discount (Undergraduate New Loan). Other rates and loan types are available. Visit Ascent's website for full details. Undergraduate and graduate loans, MBA, medical school, dental school, law school, doctorate and Master's, health professional loans. $2,001 up to $200,000 for undergraduate loans and $400,000 for graduate loans 5, 7, 10, 12, 15, 20 years Deferment and forbearance options available For DACA recipients and non-U.S. citizens or permanent residents No Terms apply. Once everything is in place, your loan funds will be sent directly to your school to cover tuition, fees and housing if applicable. If there's money left over, the school will refund it to you. Remember, you don't start paying federal student loans right away. Repayment typically begins six months after you graduate, leave school or drop below half-time enrollment — this break is called the grace period. However, PLUS loans go into repayment once the loan is disbursement. Your loan servicer will send you a repayment schedule with all the key details — including when your first payment is due, how much you'll pay and how often. You'll usually get your repayment schedule at least 30 days before your first payment is due, and your first bill at least 21 days before your first payment is due. Some things to know: Use your time in school to learn about your total loan balance and interest so you're not caught off guard later. The first step in applying for a student loan is to complete the Free Application for Federal Student Aid (FAFSA) form at To be eligible for a student loan, you need to enroll at least half-time in an accredited school, maintain satisfactory academic progress and complete the FAFSA for federal loans, or meet credit and income requirements for private loans. The 4 types of student loans are Direct Subsidized Loans, Direct Unsubsidized Loans, Direct PLUS Loans and Direct Consolidation Loans. Money matters — so make the most of it. Get expert tips, strategies, news and everything else you need to maximize your money, right to your inbox. Sign up here. At CNBC Select, our mission is to provide our readers with high-quality service journalism and comprehensive consumer advice so they can make informed decisions with their money. Every student loan article is based on rigorous reporting by our team of expert writers and editors with extensive knowledge of student loan products. While CNBC Select earns a commission from affiliate partners on many offers and links, we create all our content without input from our commercial team or any outside third parties, and we pride ourselves on our journalistic standards and ethics.
Business Wire
an hour ago
- Business Wire
NVM Express Publishes Set of NVMe Specifications, Enabling New Capabilities for AI, Cloud, Enterprise, and Client Storage
BEAVERTON, Ore.--(BUSINESS WIRE)-- NVM Express, Inc. today announced important new features and engineering change notices (ECNs) across the set of 11 NVM Express ® (NVMe ®) specifications. These advancements further strengthen NVMe technology to meet the growing demands of data-intensive AI, cloud, enterprise, and client applications. The updated specifications include: NVMe 2.3 Base Specification Command Set Specifications (NVM Command Set 1.2, ZNS Command Set 1.4, Key Value Command Set 1.3, Subsystem Local Memory Command Set 1.2, Computational Programs Command Set 1.2) Transport Specifications (NVMe over PCIe ® Transport 1.3, NVMe over RDMA Transport 1.2, NVMe over TCP Transport 1.2) NVM Express Management Interface (NVMe-MI™) 2.1 Specification NVMe Boot 1.3 Specification 'The newly released NVMe set of specifications introduces features that directly address operational challenges by empowering administrators with increased visibility and control over their storage for business-critical and data center applications,' said Amber Huffman, President of NVM Express. 'NVMe technology is architected for continuous evolution to remain the essential, high-performance interface for the storage of today and tomorrow.' Key New NVMe Features Rapid Path Failure Recovery: Permits communication with the NVM subsystem through alternative channels, allowing for rapid recovery in the event of the loss of communication to a controller to avoid data corruption and duplication of outstanding commands. Power Limit Config: Provides complete control over the maximum power of an NVMe device, particularly important for older systems with limited power capabilities. Self-reported Drive Power: Allows the host to measure and monitor NVMe device power, as well as power consumption over the lifetime of the device, addressing ongoing maintenance and sustainability concerns. Sanitize Per Namespace: Enables cryptographic erase sanitization on individual namespaces, as opposed to broadly impacting the entire NVM subsystem. Configurable Device Personality: Supports mechanisms that allow a host to securely modify the NVM subsystem configuration, easing inventory management for device providers. The NVM Express specifications and the new feature specifications are available for download on the NVM Express website. To learn more about the newly released NVMe features, attend the NVM Express presentation track on August 6 and 7 at FMS: the Future of Memory and Storage 2025, in Santa Clara, CA About NVM Express, Inc. With more than 100 members, NVM Express, Inc. is a non-profit organization focused on enabling broad ecosystem adoption of high-performance and low-latency non-volatile memory (NVM) storage through a standards-based approach. The organization offers an open collection of NVM Express ® (NVMe ®) specifications and information to fully expose the benefits of non-volatile memory in all types of computing environments from mobile to data center. NVMe-based specifications are designed from the ground up to deliver high bandwidth and low-latency storage access for current and future NVM technologies. For more information, visit The NVM Express Logo and the NVM Express, NVMe and NVMe-MI word marks are registered and unregistered, trademarks and service marks of NVM Express, Inc. in the United States and other countries. Unauthorized use is strictly prohibited.
Business Wire
an hour ago
- Business Wire
Akyso Therapeutics Expands Pipeline with New NIH Grant for Buprenorphine Implant Following Successful Phase 1a Trial of Naltrexone Implant
SALISBURY, Md.--(BUSINESS WIRE)-- Akyso Therapeutics, a privately held biotechnology company developing long-acting subcutaneous drug delivery systems, today announced two major milestones: (1) the successful completion of its first-in-human Phase 1a clinical trial of iSTEP-N®, a bioabsorbable extended-release naltrexone implant for opioid use disorder (OUD) engineered to delivery naltrexone for 12 months following a single, simple, in office treatment, and (2) the receipt of $15 million in federal funding from the National Institute on Drug Abuse (NIDA) to develop a parallel12 month buprenorphine-based implant (iSTEP-B®) for OUD. The iSTEP products represent disruptive ultra long acting formulations of both naltrexone and buprenorphine and with them Akyso Therapeutics is poised to capture a large portion of the $3B OUD treatment market in the US. Share Key Highlights: Phase 1a trial demonstrated that the iSTEP-N® implant was well-tolerated with no serious adverse events or implant-related complications. Sustained therapeutic plasma levels of naltrexone were observed for three months following a single implant. Residual Naltrexone content of the implant after 3-months suggests potential for 12-month efficacy. The iSTEP® platform utilizes a proprietary, fully bioabsorbable polymer system that does not require surgical removal. A Phase 1b study in patients with OUD is planned for early 2026 and will include a comparison to Vivitrol®. $15 million NIDA grant awarded for the development of a 6-12-month extended-release buprenorphine implant, iSTEP-B®. 'We are thrilled to share not only the success of our Phase 1a iSTEP-N® trial, but also the launch of our buprenorphine implant program with support from NIDA,' said Steven Cohen, MD, FACS, co-founder and co-CEO of Akyso Therapeutics. 'This expanded funding and validation from the NIH will allow us to pursue our dual-track approach to transforming OUD treatment with both naltrexone and buprenorphine.' Naltrexone and buprenorphine formulations represent over 90 percent of treatment options for OUD in the United States. The iSTEP products represent disruptive ultra long acting formulations of both naltrexone and buprenorphine and with them Akyso Therapeutics is poised to capture a large portion of the $3B OUD treatment market in the US. The new buprenorphine implant project builds directly upon Akyso's iSTEP® platform. iSTEP-B® will use the same bioabsorbable, subcutaneous delivery system as iSTEP-N®, with the goal of delivering therapeutic buprenorphine levels continuously for more than six months. The company plans to follow a similar clinical development pathway, including formulation, CMC analytics, GLP toxicology, and human trials. 'Our goal is to offer patients long-acting, discreet treatments that reduce relapse risk during the most vulnerable stages of recovery,' said Jeffrey Benner, MD, co-founder and co-CEO. 'With iSTEP-N® entering patient trials and iSTEP-B® now funded for development, we are well-positioned to provide scalable, very long acting, implantable therapies for both opioid and alcohol use disorders.' Akyso's iSTEP-N® program is supported in part by NIDA (UH3DA048338). A description of the Phase 1a trial is available on under the identifier NCT06053197. The new iSTEP-B® buprenorphine program is supported by a separate $15 million federal grant (2025–2029). For more information on Akyso Therapeutics or partnership opportunities, please contact:
